Traduction de «omnibus directive » (Anglais → Français) :

Directive of the European Parliament and of the Council amending Directives 2003/71/EC and 2009/138/EC and Regulations (EC) No 1060/2009, (EU) No 1094/2010 and (EU) No 1095/2010 in respect of the powers of the European Supervisory Authority (European Insurance and Occupational Pensions Authority) and the European Supervisory Authority (European Securities and Markets Authority) | Omnibus II Directive | Proposal for a Directive of the European Parliament and of the Council amending Directives 2003/71/EC and 2009/13 ...[+++]8/EC in respect of the powers of the European Insurance and Occupational Pensions Authority and the European Securities and Markets Authority

Directive 2010/78/EU amending Directives 98/26/EC, 2002/87/EC, 2003/6/EC, 2003/41/EC, 2003/71/EC, 2004/39/EC, 2004/109/EC, 2005/60/EC, 2006/48/EC, 2006/49/EC and 2009/65/EC in respect of the powers of the European Supervisory Authority (European Banking Authority), the European Supervisory Authority (European Insurance and Occupational Pensions Authority) and the European Supervisory Authority (European Securities and Markets Authority) | Omnibus I Directive

omnibus speaker circuit [ omnibus voice circuit ]

Chemical, Biological, Radiological and Nuclear Defence Omnibus Project [ CBRN Defence Omnibus Project ]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

directive (EU) [ Commission Directive | Community directive | Council Directive | European Parliament and Council directive ]

Canadian Forces Omnibus Survey Questionnaire

endemic conditions associated with environmental iodine deficiency either directly or as a consequence of maternal iodine deficiency. Some of the conditions have no current hypothyroidism but are the consequence of inadequate thyroid hormone secretion in the developing fetus. Environmental goitrogens may be associated.

Definition: A disorder characterized by impairment of memory, learning difficulties, and reduced ability to concentrate on a task for more than brief periods. There is often a marked feeling of mental fatigue when mental tasks are attempted, and new learning is found to be subjectively difficult even when objectively successful. None of these symptoms is so severe that a diagnosis of either dementia (F00-F03) or delirium (F05.-) can be made. This diagnosis should be made only in association with a specified physical disorder, and should not be made in the presence of any of the mental or behavioural disorders classified to F10-F99. The disorder may precede, accompany, or follow a wide variety of infections and physical disorders, both cerebral and syst ...[+++]emic, but direct evidence of cerebral involvement is not necessarily present. It can be differentiated from postencephalitic syndrome (F07.1) and postconcussional syndrome (F07.2) by its different etiology, more restricted range of generally milder symptoms, and usually shorter duration.

The Commission has decided to send reasoned opinions to the Czech Republic, Ireland and the Netherlands requesting them to fully implement the Solvency II Directive (Directive 2009/138/EC) and the Omnibus II Directive (Directive 2014/51/EU).

The Commission has requested Latvia, Hungary, Poland and Portugal to fully transpose the Solvency II Directive (Directive 2009/138/EC) and the Omnibus II Directive (Directive 2014/51/EU), and Cyprus to fully transpose the Omnibus II Directive into their national legislation.

The European Commission has requested Bulgaria, Greece, Luxembourg, Sloveniaand Sweden to transpose the Solvency II Directive (Directive 2009/138/EC) and the Omnibus II Directive (Directive 2014/51/EU) into their national legislation. These Directives replace the 14 insurance and reinsurance directives that were previously known as "Solvency I" (see MEMO/15/3120 of 12 January 2015). They introduce for the first time a harmonised, sound and robust prudential framework for insurance firms in the EU, including quantitative, governance an ...[+++]d reporting rules, to facilitate the development of a single market in insurance services.

The Omnibus II proposal also includes provisions to postpone the date for transposition and the date of application of Directive 2009/138/EC, and the date of repeal of Solvency I, and serves as a means to adapt Directive 2009/138/EC to the entry into force of the Treaty on the Functioning of the European Union by converting the provisions empowering the Commission to adopt implementing measures into provisions empowering the Commission to adopt delegated and implementing acts.